Roche’s virtual analyst event during ESMO IO
Agenda
Welcome
CITYSCAPE updated analysis: Tiragolumab + Tecentriq in 1L NSCLC
Tiragolumab development overview
Q&A
Karl Mahler, Head of Investor Relations
Raymond Meng, M.D., Ph.D. - Global Development Leader Tiragolumab
Heather Stevens, MBA, MPH - Life Cycle Leader, Tiragolumab

Please register to access the replay*

*Privacy notice

Live Webinar Replay

Roche has hosted a virtual event on Friday, 10 December 2021.

Investors
Past IR Events
View more Events

Downloads

Related links